Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents

<div>A schematic representation of cell-based therapies in multiple sclerosis. AHSCT: autologous hematopoietic stem cell transplantation; MSCs: mesenchymal stem cells; OPCs: oligodendrocyte progenitor cells; iPSCs: induced pluripotent stem cells.</div>

Stem Cells International

fig2

Figure 2

Figure 2: Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel Agents 